We can’t show the full text here under this license.
Abstract
Dyslipidemia is a leading modifiable risk factor for atherosclerotic cardiovascular disease.
- The gut microbiota plays a critical role in regulating lipid levels through various mechanisms.
- Dietary components, probiotics, and prebiotics may influence gut microbiota and lipid homeostasis.
- Underexplored factors such as circadian rhythms and population-specific microbial signatures may impact dyslipidemia management.
- Addressing these factors could enhance the application of microbiome research in treating dyslipidemia.
Simplified